Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma
Alyssa L. Kennedy(Boston Children's Hospital), Kimberly Stegmaier(Broad Institute)
Cited by 98
Related Papers
Gene expression–based high-throughput screening(GE-HTS) and application to leukemia differentiation
|Nature Genetics|2004|269
Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome
|Nature Communications|2021|172
CRISPR-Cas9 screen reveals a MYCN-amplified neuroblastoma dependency on EZH2
|Journal of Clinical Investigation|2017|159
The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia
|Journal of Clinical Investigation|2012|104